Welcome to our dedicated page for Costamare SEC filings (Ticker: CMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Costamare's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Costamare's regulatory disclosures and financial reporting.
Morgan Stanley Smith Barney LLC reported a Form 144 notice for the proposed sale of 94,895 shares of Common stock with an aggregate value of $1,466,592.74. The filing identifies Achillefs Konstantakopoulos as the related holder and lists two recent dispositions in the prior three months: 141,682 shares on 05/28/2026 for $2,255,690.79 and 73,627 shares on 05/27/2026 for $1,198,235.25.
ACHILLEFS KONSTANTAKOPOULOS submitted a Form 144 notice proposing the sale of 141,682 shares of common stock of the issuer via Morgan Stanley Smith Barney LLC. The shares were acquired 05/25/2017 in a Private Acquisition from Issuer/Affiliate. The filer also reported 73,627 shares sold on 05/27/2026 for $1,198,235.25.
Costamare Inc. reported Q1 2026 net income from continuing operations of $81.9 million, down from $111.9 million a year earlier, on total revenues of $211.1 million versus $222.9 million. Net income available to common stockholders was $75.3 million, with earnings per common share of $0.62 compared with $0.79 in Q1 2025.
Total assets increased to $3.93 billion as of March 31, 2026, while total long-term debt was $1.50 billion. Operating cash flow from continuing operations was $112.4 million. The container vessels segment generated segment profit of $87.1 million and the NML leaseback segment $6.5 million.
Christos Konstantakopoulos reported multiple common stock dispositions for CMRE in May 2026. The filing lists sales on 05/06/2026, 05/07/2026, 05/08/2026, 05/11/2026, 05/12/2026, and 05/13/2026, with individual trade sizes shown in the filing.
The record also lists prior open-market purchases executed on 02/06/2018 (89,684 shares) and 11/06/2017 (21,762 shares). The entries include per-trade dollar amounts alongside share counts.
Christos Konstantakopoulos reported proposed sales of Common Stock on a Form 144. The filing lists multiple open-market sales dated 05/06/2026 through 05/12/2026, with individual transactions showing share counts and gross proceeds for each sale.
Christos Konstantakopoulos submitted a notice proposing sales of common shares of CMRE. The filing lists multiple recent open‑market dispositions: 110,234 shares on 05/11/2026 ($1,906,585.22), 93,066 on 05/08/2026 ($1,644,708.89), 122,186 on 05/07/2026 ($2,123,433.84), and 93,598 on 05/06/2026 ($1,617,410.88).
The notice also records earlier open‑market purchases dated 11/06/2017 and 08/07/2017 with listed share amounts. The filing is a routine affiliate sales notice and provides transaction dates, share counts, and gross proceeds for the reported trades.
Christos Konstantakopoulos reported dispositions of Common shares of CMRE. The Form 144 excerpt lists proposed open-market sales and records three recent sales: 05/08/2026 of 93,066 shares for $1,644,708.89, 05/07/2026 of 122,186 shares for $2,123,433.84, and 05/06/2026 of 93,598 shares for $1,617,410.88.
CMRE reported sales of restricted/Common stock by Christos Konstantakopoulos on 05/07/2026 and 05/06/2026.
The filing lists 122,186 shares with $2,123,433.84 and 93,598 shares with $1,617,410.88 respectively. Earlier open‑market purchases by Morgan Stanley Smith Barney LLC from 2017 are also shown.
Christos Konstantakopoulos reported proposed sales of Common shares under Form 144. The filing lists 122,186 shares associated with Morgan Stanley Smith Barney LLC as broker and a separate reported sale of 93,598 shares on 05/06/2026. Cash amounts shown include $2,123,433.84 and $1,617,410.88.